Die Suchmaschine für Unternehmensdaten in Europa

EU-Förderung (4.000.000 €): Jenseits von 1M Genomen Hor 01.06.2020 EU-Rahmenprogramm für Forschung und Innovation "Horizont"

Text

Jenseits von 1M Genomen

The Beyond 1 Million Genomes (B1MG) consortium will establish the support and coordination structure for the European 1+ Million Genomes initiative (1+MG), which is based upon the commitment of 20 European Member States and Norway that have signed the Declaration ‘Towards access to at least 1 million sequenced genomes in the EU by 2022’. Collectively, these countries have committed to establish a cross-border federated network of national genome collections associated with phenotypic data, consented for advancing health and medicine practices across Europe. Europe is uniquely placed to take on this challenge and position itself as a global leader in this field. B1MG will go ‘beyond’ the 1M genome target and ‘beyond’ the 20 signatory countries. The project will collaborate with an array of international initiatives and consult a range of stakeholders to support the creation of a pan-European genome-based health data infrastructure, encompassing data quality and exchange standards, access protocols and legal guidance. Recommendations will be translated to a B1MG maturity level model that provides concrete guidance on the steps required to implement personalised medicine, a healthcare approach that takes into account a person’s genetic make-up, at local, regional and national-scale. Personalised medicine is expected to bring significant socio-economic benefits, including more efficient national health systems. Faster and more accurate diagnosis, the development of pharmacogenomics and advancement of preventative medicine will lead to better health, quality of life of patients and increased life expectancy. This will be captured in a methodology for economic evaluation, forming the basis of future business-cases for implementation in the health sector.


Geförderte Unternehmen:

Firmenname Förderungssumme
Alleanza Contro IL Cancro 56.250 €
Biobanks AND Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric) 151.960 €
Centre National de la Recherche Scientifique CNRS 21.081 €
Consiglio Nazionale Delle Ricerche 0,00 €
CSC-Tieteen Tietotekniikan Keskus Oy 262.251 €
Eatris Eric 75.332 €
Ecrin European Clinical Research Infrastructure Network 76.334 €
European Alliance for Personalised Medicine 159.428 €
European Molecular Biology Laboratory 1.218.841 €
Fundacio Centre de Regulacio Genomica 188.078 €
Helsingin Yliopisto 56.250 €
Idryma Iatroviologikon Ereunon Akademias Athinon 0,00 €
Instituto de Salud Carlos III 108.987 €
Instituto Nacional de Saude DR. Ricardo Jorge 240.065 €
Karolinska Institutet 21.758 €
Katholieke Universiteit Leuven 61.204 €
Latvijas Biomedicinas Petijumu UN Studiju Centrs 0,00 €
Legal Pathways B.V. 69.165 €
Orszagos Onkologiai Intezet 17.704,05 €
Ospedale Pediatrico Bambino Gesu 56.250 €
Ospedale SAN Raffaele Srl 0,00 €
Pned GIE 124.730 €
Stichting Amsterdam UMC 312.550 €
Stichting DTL Projects 140.810 €
Stichting Hartwig Medical Foundation 2.704,05 €
Stichting Health-RI 14.000,00 €
Stichting HET Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis 0,00 €
Stichting Lygature 117.620 €
Stichting Nationaal ICT Instituut IN DE Zorg 42.825 €
Stockholms Universitet 0,00 €
Tartu Ulikool 93.954 €
Tervise Arengu Instituut 6.454,05 €
Universita Degli Studi Di Milano 21.447 €
Universitair Medisch Centrum Utrecht 2.704,05 €
Universite Du Luxembourg 135.104 €
Universitetet I Oslo 23.741 €
Univerza V Ljubljani 19.954,05 €
Univerzita Karlova 17.294,55 €
Uppsala Universitet 83.170 €

Quelle: https://cordis.europa.eu/project/id/951724

Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.